Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DUANE E PATTERSON

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1154054344
CMS profile
11347008
Location
CENTRALIA, WA

General Payments · PY2024

$546.38

  • Reported across 15 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$546.38

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $534.23 14
Education $12.15 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $206.72 6
ITI, Inc. $157.86 5
Axsome Therapeutics, Inc. $125.00 1
Alkermes, Inc. $23.48 1
Sage Therapeutics, Inc. $18.79 1
Otsuka America Pharmaceutical, Inc. $14.53 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2024 $546.38 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alkermes, Inc. $23.48 01/09/2024 Food and Beverage Undisputed 01/23/2026 1120571305 CMS
Axsome Therapeutics, Inc. $125.00 03/13/2024 Food and Beverage Undisputed 01/23/2026 1148355600 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.52 02/21/2024 Food and Beverage Undisputed 01/23/2026 1143579731 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $7.39 03/15/2024 Food and Beverage Undisputed 01/23/2026 1143579733 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.80 04/26/2024 Food and Beverage Undisputed 01/23/2026 1143579735 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.15 06/03/2024 Education Undisputed 01/23/2026 1143579737 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $125.00 06/04/2024 Food and Beverage Undisputed 01/23/2026 1143579739 CMS
Otsuka America Pharmaceutical, Inc. $14.53 04/29/2024 Food and Beverage Undisputed 01/23/2026 1119159537 CMS
Sage Therapeutics, Inc. $18.79 07/09/2024 Food and Beverage Undisputed 01/23/2026 1120401040 CMS
Teva Pharmaceuticals USA, Inc. $125.00 02/07/2024 Food and Beverage Undisputed 01/23/2026 1151518355 CMS
Teva Pharmaceuticals USA, Inc. $10.78 04/02/2024 Food and Beverage Undisputed 01/23/2026 1151518385 CMS
Teva Pharmaceuticals USA, Inc. $28.32 04/10/2024 Food and Beverage Undisputed 01/23/2026 1151518399 CMS
Teva Pharmaceuticals USA, Inc. $27.62 04/22/2024 Food and Beverage Undisputed 01/23/2026 1151518401 CMS
Teva Pharmaceuticals USA, Inc. $8.51 05/09/2024 Food and Beverage Undisputed 01/23/2026 1151518403 CMS
Teva Pharmaceuticals USA, Inc. $6.49 06/03/2024 Food and Beverage Undisputed 01/23/2026 1151518405 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2024
Source files
Dataset page · Bulk file · PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.